Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Bioorganic and Medicinal Chemistry Année : 2015

Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series

Résumé

An antileishmanial pharmacomodulation at position 4 of 8-nitroquinolin-2(1H)-one was conducted by using the Sonogashira and Suzuki-Miyaura coupling reactions. A series of 25 derivatives was tested in vitro on the promastigote stage of Leishmania donovani along with an in vitro cytotoxicity evaluation on the human HepG2 cell line. Only the derivatives bearing a phenyl moiety at position 4 of the quinoline ring displayed interesting biologic profile, when the phenyl moiety was substituted at the para position by a Br or Cl atom, or by a CF3 group. Among them, molecules 17 and 19 were the most selective and were then tested in vitro on the intracellular amastigote stage of both L. donovani and Leishmania infantum, in parallel with complementary in vitro cytotoxicity assays on the macrophage cell lines THP-1 and J774A.1. Molecule 19 showed no activity on the amastigote stages of the parasites and some cytotoxicity on the J774A.1 cell line while molecule 17, less cytotoxic than 19, showed anti-amastigote activity in L. infantum, being 3 times less active than miltefosine but more active and selective than pentamidine. Nevertheless, hit-molecule 17 did not appear as selective as the parent compound. (C) 2015 Elsevier Ltd. All rights reserved.

Domaines

Chimie
Fichier non déposé

Dates et versions

hal-01460646 , version 1 (07-02-2017)

Identifiants

Citer

Charline Kieffer, Anita Cohen, Pierre Verhaeghe, Lucie Paloque, Sébastien Hutter, et al.. Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series. Bioorganic and Medicinal Chemistry, 2015, 23 (10), pp.2377-2386. ⟨10.1016/j.bmc.2015.03.064⟩. ⟨hal-01460646⟩
149 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More